

Cover Story
On Sept. 4, Jay Bhattacharya did something NIH directors rarely do: he appeared before the National Cancer Advisory Board, speaking directly with the NCI advisory board about hot-button policy changes taking place under his leadership at NIH.
Cancer Policy
In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for September 2025
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
- CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
Cancer advocates express concern about comments that signal trouble for accelerated approval - Mary Pazdur, 63, Dies of Cancer; What Her Husband Has Learned
- How George Tidmarsh crossed the FDA-industry Rubicon
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA





















